Clinical Trial Update: Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating denosumab for hypercalcemia of malignancy in cancer patients; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hypercalcemia of Malignancy

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Amgen | Conditions: Breast Cancer, Hypercalcemia of Malignancy | Phase 2 | Status: COMPLETED | Results posted: 2015-01-01